在骨髓瘤中AMPK信号的多功能功能:一个老玩家,具有新的新兴致癌功能
Mehrdad Hashemi1, Mehrnaz Razzazan2, Maryam Bagheri3
1Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Pathology, research and practice
|October 14, 2023
概括
AMP激活蛋白激酶 (AMPK) 信号传递在骨髓瘤 (OS) 的进展和治疗中起着复杂的作用. 了解 AMPKK 的理解
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 骨髓瘤 (OS) 是一种具有不良预后的侵袭性骨癌,特别是在转移或复发的情况下.
- AMP激活蛋白激酶 (AMPK) 信号传递与癌症相关的各种细胞过程有关.
- 在OS中AMPK的确切作用仍然很复杂,具有作为瘤抑制剂或促进剂的潜在双重功能.
研究的目的:
- 审查AMPK信号在骨髓瘤中的调节机制和功能作用.
- 探索针对OS治疗的AMPK信号的治疗潜力.
- 突出需要进一步研究AMPK的机制和OS中的治疗应用.
主要方法:
- 关于骨髓瘤中AMPK信号传递研究的文献综述.
- 对AMPK分子激活通路的分析.
- 检查AMPK与OS细胞增殖,细胞亡和新陈代谢的相互作用.
- 对针对AMPK信号的治疗药物的审查.
主要成果:
- AMPK信号影响OS中的关键细胞过程,包括增殖,亡和新陈代谢.
- 在癌症中,AMPK可以作为瘤抑制剂和促进剂,包括OS.
- 几种化合物,如甲福明和白醇,显示了在OS治疗中准AMPK的潜力.
结论:
- AMPK信号传递与骨髓瘤密切相关,因此需要全面了解其分子机制.
- 针对AMPK信号提供了一个有前途的途径,用于OS的新型治疗策略.
- 进一步的研究至关重要,以优化剂量,了解毒性,并阐明AMPK向剂的精确抗骨髓瘤作用.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


